Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Many neurogenetic disorders are caused by the mutation of ubiquitously expressed genes. One such disorder, spinal muscular atrophy, is caused by loss or mutation of the survival motor neuron1 gene (SMN1), leading to reduced SMN protein levels and a selective dysfunction of motor neurons. SMN, together with partner proteins, functions in the assembly of small nuclear ribonucleoproteins (snRNPs), which are important for pre-mRNA splicing. It has also been suggested that SMN might function in the assembly of other ribonucleoprotein complexes. Two hypotheses have been proposed to explain the molecular dysfunction that gives rise to spinal muscular atrophy (SMA) and its specificity to a particular group of neurons. The first hypothesis states that the loss of SMN's well-known function in snRNP assembly causes an alteration in the splicing of a specific gene (or genes). The second hypothesis proposes that SMN is crucial for the transport of mRNA in neurons and that disruption of this function results in SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also of particular relevance is the possible role of HuD in spinal muscular atrophy (SMA), a disease that results in degeneration of spinal cord motor neurons due to deletion or loss-of-function mutations in the survival of motor neuron 1 (SMN1) gene, resulting in inadequate expression of functional SMN protein (Burghes and Beattie 2009).”
From Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction (2013) · cites this paper as Burghes and Beattie 2009
Experimental — accuracy not yet measuredIn the citing paper
“SMA is a devastating neurodegenerative disease resulting from progressive loss of motor neurons.1”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“cgi?id=105400">amyotrophic lateral sclerosis (caused by mutations in superoxide dismutase 1 ( SOD1 )”
BackgroundCorrelation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Self-citationNon-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Cited by
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710504 · Cited by 1,433
The changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression
Bernard, D., Prasanth, K. V., Tripathi, V., Colasse, S., Nakamura, T., Xuan, Z., Zhang, M. Q., Sedel, F., Jourdren, L., Coulpier, F., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.199 · Cited by 735
Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H. M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1610 · Cited by 688
Self-citationRetractedMolecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., et al. (2014) · Science · doi:10.1126/science.1250127 · Cited by 524
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Spinal muscular atrophy: Diagnosis and management in a new therapeutic era
Arnold, W. D., Kassar, D., & Kissel, J. T. (2015) · Muscle & Nerve · doi:10.1002/mus.24497 · Cited by 436
Mentis, G. Z., Blivis, D., Liu, W., Drobac, E., Crowder, M. E., Kong, L., Alvarez, F. J., Sumner, C. J., & O'Donovan, M. J. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.032 · Cited by 381
Spinal muscular atrophy: going beyond the motor neuron
Hamilton, G., & Gillingwater, T. H. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.002 · Cited by 381
Bevan, A. K., Duque, S., Foust, K. D., Morales, P. R., Braun, L., Schmelzer, L., Chan, C. M., McCrate, M., Chicoine, L. G., Coley, B. D., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.157 · Cited by 337
Self-citationSpinal Muscular Atrophy: A Timely Review
Kolb, S. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.74 · Cited by 333
Shan, X., Chiang, P.-M., Price, D. L., & Wong, P. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003459107 · Cited by 318
An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function
Lotti, F., Imlach, W. L., Saieva, L., Beck, E. S., Hao, L. T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.012 · Cited by 316
Self-citationPassini, M. A., Bu, J., Roskelley, E. M., Richards, A. M., Sardi, S. P., O’Riordan, C. R., Klinger, K. W., Shihabuddin, L. S., & Cheng, S. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41615 · Cited by 292
Rigo, F., Chun, S. J., Norris, D. A., Hung, G., Lee, S., Matson, J., Fey, R. A., Gaus, H., Hua, Y., Grundy, J. S., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.212407 · Cited by 283
“protein causes disease, it is widely believed that a recovery in the levels of SMN protein should provide a therapeutic benefit (Burghes and Beattie, 2009).”
BackgroundA single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Porensky, P. N., Mitrpant, C., McGovern, V. L., Bevan, A. K., Foust, K. D., Kaspar, B. K., Wilton, S. D., & Burghes, A. H. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr600 · Cited by 248
Self-citationEmerging therapies and challenges in spinal muscular atrophy
Farrar, M. A., Park, S. B., Vucic, S., Carey, K. A., Turner, B. J., Gillingwater, T. H., Swoboda, K. J., & Kiernan, M. C. (2017) · Annals of Neurology · doi:10.1002/ana.24864 · Cited by 247
SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination
Yanling Zhao, D., Gish, G., Braunschweig, U., Li, Y., Ni, Z., Schmitges, F. W., Zhong, G., Liu, K., Li, W., Moffat, J., et al. (2016) · Nature · doi:10.1038/nature16469 · Cited by 236
Drosophila melanogaster in the Study of Human Neurodegeneration
Hirth, F. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791556104 · Cited by 235
Zebrafish models of human motor neuron diseases: Advantages and limitations
Babin, P. J., Goizet, C., & Raldúa, D. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.03.001 · Cited by 227
Fallini, C., Zhang, H., Su, Y., Silani, V., Singer, R. H., Rossoll, W., & Bassell, G. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3631-10.2011 · Cited by 221
The role of survival motor neuron protein (SMN) in protein homeostasis
Chaytow, H., Huang, Y.-T., Gillingwater, T. H., & Faller, K. M. E. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2849-1 · Cited by 217
Spinal muscular atrophy: The role of SMN in axonal mRNA regulation
Fallini, C., Bassell, G. J., & Rossoll, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.044 · Cited by 215
Ling, K. K. Y., Lin, M.-Y., Zingg, B., Feng, Z., & Ko, C.-P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015457 · Cited by 215
Spinal muscular atrophy: mechanisms and therapeutic strategies
Lorson, C. L., Rindt, H., & Shababi, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq147 · Cited by 209
Bevan, A. K., Hutchinson, K. R., Foust, K. D., Braun, L., McGovern, V. L., Schmelzer, L., Ward, J. G., Petruska, J. C., Lucchesi, P. A., Burghes, A. H. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq300 · Cited by 209
Self-citationSpliceosome integrity is defective in the motor neuron diseases ALS and SMA
Tsuiji, H., Iguchi, Y., Furuya, A., Kataoka, A., Hatsuta, H., Atsuta, N., Tanaka, F., Hashizume, Y., Akatsu, H., Murayama, S., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202303 · Cited by 208
Cardiac defects contribute to the pathology of spinal muscular atrophy models
Shababi, M., Habibi, J., Yang, H. T., Vale, S. M., Sewell, W. A., & Lorson, C. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq329 · Cited by 207
Martinez, T. L., Kong, L., Wang, X., Osborne, M. A., Crowder, M. E., Van Meerbeke, J. P., Xu, X., Davis, C., Wooley, J., Goldhamer, D. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0204-12.2012 · Cited by 207
Spinal muscular atrophy — insights and challenges in the treatment era
Mercuri, E., Pera, M. C., Scoto, M., Finkel, R., & Muntoni, F. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-00413-4 · Cited by 206
Regulation of alternative splicing by the core spliceosomal machinery
Saltzman, A. L., Pan, Q., & Blencowe, B. J. (2011) · Genes & Development · doi:10.1101/gad.2004811 · Cited by 206
Akten, B., Kye, M. J., Hao, L. T., Wertz, M. H., Singh, S., Nie, D., Huang, J., Merianda, T. T., Twiss, J. L., Beattie, C. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104928108 · Cited by 203
Self-citationLing, K. K. Y., Gibbs, R. M., Feng, Z., & Ko, C.-P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr453 · Cited by 201
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
Nishio, H., Niba, E. T. E., Saito, T., Okamoto, K., Takeshima, Y., & Awano, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511939 · Cited by 201
SMN Is Required for Sensory-Motor Circuit Function in Drosophila
Imlach, W. L., Beck, E. S., Choi, B. J., Lotti, F., Pellizzoni, L., & McCabe, B. D. (2012) · Cell · doi:10.1016/j.cell.2012.09.011 · Cited by 199
AAV-based in vivo gene therapy for neurological disorders
Ling, Q., Herstine, J. A., Bradbury, A., & Gray, S. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00766-7 · Cited by 197
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández-Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas-García, R., Riancho, J., & López de Munain, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 194
Butchbach, M. E. R. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00007 · Cited by 193
Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit
Van Alstyne, M., Tattoli, I., Delestrée, N., Recinos, Y., Workman, E., Shihabuddin, L. S., Zhang, C., Mentis, G. Z., & Pellizzoni, L. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00827-3 · Cited by 188
Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy
Tisdale, S., & Pellizzoni, L. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0417-15.2015 · Cited by 187
Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy
Zhang, Z., Pinto, A. M., Wan, L., Wang, W., Berg, M. G., Oliva, I., Singh, L. N., Dengler, C., Wei, Z., & Dreyfuss, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319280110 · Cited by 182
Al-Zaidy, S. A., & Mendell, J. R. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.06.007 · Cited by 182
Song, M., Yang, X., Ren, X., Maliskova, L., Li, B., Jones, I. R., Wang, C., Jacob, F., Wu, K., Traglia, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0472-1 · Cited by 177
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
Wishart, T. M., Mutsaers, C. A., Riessland, M., Reimer, M. M., Hunter, G., Hannam, M. L., Eaton, S. L., Fuller, H. R., Roche, S. L., Somers, E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71318 · Cited by 176
The clinical landscape for SMA in a new therapeutic era
Talbot, K., & Tizzano, E. F. (2017) · Gene Therapy · doi:10.1038/gt.2017.52 · Cited by 174
Targeting RNA to treat neuromuscular disease
Muntoni, F., & Wood, M. J. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3459 · Cited by 171
Genetically Engineered Pig Models for Human Diseases
Prather, R. S., Lorson, M., Ross, J. W., Whyte, J. J., & Walters, E. (2013) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-031412-103715 · Cited by 170
Chen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093297 · Cited by 165
Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy
Neil, E. E., & Bisaccia, E. K. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.3.194 · Cited by 162
Nusinersen for the treatment of spinal muscular atrophy
Chiriboga, C. A. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1364159 · Cited by 162
Structural basis of a small molecule targeting RNA for a specific splicing correction
Campagne, S., Boigner, S., Rüdisser, S., Moursy, A., Gillioz, L., Knörlein, A., Hall, J., Ratni, H., Cléry, A., & Allain, F. H.-T. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0384-5 · Cited by 162
Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation
Kariya, S., Obis, T., Garone, C., Akay, T., Sera, F., Iwata, S., Homma, S., & Monani, U. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72017 · Cited by 162
SMN control of RNP assembly: From post-transcriptional gene regulation to motor neuron disease
Li, D. K., Tisdale, S., Lotti, F., & Pellizzoni, L. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.04.026 · Cited by 161
Dynamic force-induced direct dissociation of protein complexes in a nuclear body in living cells
Poh, Y., Shevtsov, S. P., Chowdhury, F., Wu, D. C., Na, S., Dundr, M., & Wang, N. (2012) · Nature Communications · doi:10.1038/ncomms1873 · Cited by 160
How to make spinal motor neurons
Davis‐Dusenbery, B. N., Williams, L. A., Klim, J. R., & Eggan, K. C. (2014) · Development · doi:10.1242/dev.097410 · Cited by 160
Constructing and Deconstructing Stem Cell Models of Neurological Disease
Han, S. S. W., Williams, L. A., & Eggan, K. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.003 · Cited by 159
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy
Wishart, T. M., Huang, J. P.-W., Murray, L. M., Lamont, D. J., Mutsaers, C. A., Ross, J., Geldsetzer, P., Ansorge, O., Talbot, K., Parson, S. H., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq340 · Cited by 159
SMN regulates axonal local translation via miR-183/mTOR pathway
Kye, M. J., Niederst, E. D., Wertz, M. H., Gonçalves, I. D. C. G., Akten, B., Dover, K. Z., Peters, M., Riessland, M., Neveu, P., Wirth, B., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu350 · Cited by 158
Sareen, D., Ebert, A. D., Heins, B. M., McGivern, J. V., Ornelas, L., & Svendsen, C. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039113 · Cited by 158
Pedrotti, S., Bielli, P., Paronetto, M. P., Ciccosanti, F., Fimia, G. M., Stamm, S., Manley, J. L., & Sette, C. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.19 · Cited by 158
Spinal Muscular Atrophy: Manifestations and Management
Mesfin, A., Sponseller, P. D., & Leet, A. I. (2012) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-20-06-393 · Cited by 156
A large animal model of spinal muscular atrophy and correction of phenotype
Duqué, S. I., Arnold, W. D., Odermatt, P., Li, X., Porensky, P. N., Schmelzer, L., Meyer, K., Kolb, S. J., Schümperli, D., Kaspar, B. K., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24332 · Cited by 154
Self-citationMurray, L. M., Talbot, K., & Gillingwater, T. H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01061.x · Cited by 153
A novel function for the survival motoneuron protein as a translational regulator
Sanchez, G., Dury, A. Y., Murray, L. M., Biondi, O., Tadesse, H., Fatimy, R. E., Kothary, R., Charbonnier, F., Khandjian, É. W., & Côté, J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds474 · Cited by 152
Spinal muscular atrophy: A changing phenotype beyond the clinical trials
Tizzano, E. F., & Finkel, R. S. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.05.011 · Cited by 151
Lee, Y. I., Mikesh, M., Smith, I., Rimer, M., & Thompson, W. J. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.05.667 · Cited by 148
PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons
Ning, K., Drepper, C., Valori, C. F., Ahsan, M., Wyles, M., Higginbottom, A., Herrmann, T., Shaw, P. J., Azzouz, M., & Sendtner, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq226 · Cited by 146
Ng, S., Soh, B.-S., Rodríguez‐Muela, N., Hendrickson, D. G., Price, F. D., Rinn, J. L., & Rubin, L. L. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.08.003 · Cited by 144
Jangi, M., Fleet, C., Cullen, P. F., Gupta, S. V., Mekhoubad, S., Chiao, E. T., Allaire, N., Bennett, C. F., Rigo, F., Krainer, A. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613181114 · Cited by 141
Astrocytes influence the severity of spinal muscular atrophy
Rindt, H., Feng, Z., Mazzasette, C., Glascock, J., Valdivia, D. O., Pyles, N. J., Crawford, T. O., Swoboda, K. J., Patitucci, T. N., Ebert, A. D., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv148 · Cited by 140
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Bordet, T., Berna, P. P., Abitbol, J., & Pruss, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3020345 · Cited by 140
Rodent models of TDP-43: Recent advances
Tsao, W., Jeong, Y. H., Lin, S. Z., Ling, J. P., Price, D. L., Chiang, P., & Wong, P. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.031 · Cited by 139
Spinal muscular atrophy—recent therapeutic advances for an old challenge
Faravelli, I., Nizzardo, M., Comi, G. P., & Corti, S. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.77 · Cited by 138
Hubers, L., Valderrama-Carvajal, H., Laframboise, J., Timbers, J., Sanchez, G., & Côté, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq500 · Cited by 138
Kissel, J. T., Scott, C., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., Acsádi, G., Elsheik, B., Schroth, M. K., D’Anjou, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021296 · Cited by 138
Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data
Chen, X., Sanchis-Juan, A., French, C. E., Connell, A. J., Delon, I., Kingsbury, Z., Chawla, A., Halpern, A. L., Taft, R. J., Bentley, D. R., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0754-0 · Cited by 137
Temporal requirement for high SMN expression in SMA mice
Le, T. T., McGovern, V. L., Alwine, I. E., Wang, X., Massoni‐Laporte, A., Rich, M. M., & Burghes, A. H. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr275 · Cited by 136
Self-citationAmyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 134
Bernabò, P., Tebaldi, T., Groen, E. J. N., Lane, F. M., Perenthaler, E., Mattedi, F., Newbery, H. J., Zhou, H., Zuccotti, P., Potrich, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.010 · Cited by 134
Genetically modified pig models for neurodegenerative disorders
Holm, I. E., Alstrup, A. K. O., & Luo, Y. (2015) · The Journal of Pathology · doi:10.1002/path.4654 · Cited by 133
Anesthesia and spinal muscle atrophy
Islander, G. (2013) · Pediatric Anesthesia · doi:10.1111/pan.12159 · Cited by 129
Ruggiu, M., McGovern, V. L., Lotti, F., Saieva, L., Li, D. K., Kariya, S., Monani, U. R., Burghes, A. H. M., & Pellizzoni, L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06077-11 · Cited by 128
Self-citationAjiro, M., Jia, R., Yang, Y., Zhu, J., & Zheng, Z. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1500 · Cited by 127
Cardiac pathology in spinal muscular atrophy: a systematic review
Wijngaarde, C. A., Blank, A. C., Stam, M., Wadman, R. I., van den Berg, L. H., & van der Pol, W. L. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0613-5 · Cited by 127
Bronicki, L. M., & Jasmin, B. J. (2013) · RNA · doi:10.1261/rna.039164.113 · Cited by 126
Glinka, M., Herrmann, T., Funk, N., Havlicek, S., Rossoll, W., Winkler, C., & Sendtner, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq073 · Cited by 126
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Emerging Evidence of Translational Control by AU-Rich Element-Binding Proteins
Otsuka, H., Fukao, A., Funakami, Y., Duncan, K. E., & Fujiwara, T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00332 · Cited by 121
Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1
Cléry, A., Jayne, S., Benderska, N., Dominguez, C., Stamm, S., & Allain, F. H. ‐. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2001 · Cited by 121
Motor neuron mitochondrial dysfunction in spinal muscular atrophy
Miller, N., Shi, H., Zelikovich, A. S., & Ma, Y.-C. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw262 · Cited by 119
Bicaudal D Family of Motor Adaptors: Linking Dynein Motility to Cargo Binding
Hoogenraad, C. C., & Akhmanova, A. S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.001 · Cited by 119
Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy
Simon, C. M., Dai, Y., Alstyne, M. V., Koutsioumpa, C., Pagiazitis, J. G., Chalif, J. I., Wang, X., Rabinowitz, J. E., Henderson, C. E., Pellizzoni, L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.003 · Cited by 117
Butchbach, M. E. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157896 · Cited by 117
Reversible molecular pathology of skeletal muscle in spinal muscular atrophy
Mutsaers, C. A., Wishart, T. M., Lamont, D. J., Rießland, M., Schreml, J., Comley, L. H., Murray, L. M., Parson, S. H., Lochmüller, H., Wirth, B., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr360 · Cited by 116
Metadata
- Authors
- Burghes, A. H. M., & Beattie, C. E.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Burghes, Arthur H. M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-08
- Volume
- 10
- Issue
- 8
- Pages
- 597-609
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC2853768
- OpenAlex
- W2148071380
- Cited by
- 723
- References
- 176
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 28 · 2023: 33 · 2022: 33 · 2021: 41 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 54 · 2016: 50 · 2015: 50 · 2014: 46 · 2013: 56 · 2012: 43
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS038650, R01NS041649)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- spinal muscular atrophy, survival motor neuron protein, SMN1, motor neuron dysfunction, small nuclear ribonucleoproteins, pre-mRNA splicing, ribonucleoprotein assembly, mRNA transport, loss-of-function mutations, neurodegeneration
- MeSH terms
- Humans, Models, Biological, Motor Neurons, Muscular Atrophy, Spinal, Ribonucleoproteins, Small Nuclear, Survival of Motor Neuron 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.